BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4381869)

  • 21. Inhibition of catecholamine synthesis and conditioned avoidance acquisition.
    Ahlenius S
    Pharmacol Biochem Behav; 1973; 1(3):347-50. PubMed ID: 4775861
    [No Abstract]   [Full Text] [Related]  

  • 22. Alterations in behavior and brain catecholamine levels in rats treated with alpha-methyltyrosine.
    Rech RH; Borys HK; Moore KE
    J Pharmacol Exp Ther; 1966 Sep; 153(3):412-9. PubMed ID: 5922318
    [No Abstract]   [Full Text] [Related]  

  • 23. Pituitary-adrenal activity and depletion of brain catecholamines after -methyl-p-tyrosine administration.
    Kaplanski J; Dorst W; Smelik PG
    Eur J Pharmacol; 1972 Nov; 20(2):238-40. PubMed ID: 4651212
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of catecholamine synthesis inhibition on ethanol narcosis in mice.
    Blum K; Merritt JH; Wallace JE; Owen R; Hahn JW; Geller I
    Curr Ther Res Clin Exp; 1972 Jun; 14(6):324-9. PubMed ID: 4625804
    [No Abstract]   [Full Text] [Related]  

  • 25. [Characteristics and functions of intraneuronal compartments of monoamines in the central nervous system].
    Gowinski J; Besson MJ; Cheramy A; Javoy F; Thierry AM
    Rev Neurol (Paris); 1972 Jul; 127(1):1-22. PubMed ID: 4677511
    [No Abstract]   [Full Text] [Related]  

  • 26. The effects of two inhibitors of catecholamine synthesis on the content of noradrenaline and dopamine of the rat brain.
    Goodchild MA; Brownlee G
    Br J Pharmacol; 1969 May; 36(1):203P-204P. PubMed ID: 5768113
    [No Abstract]   [Full Text] [Related]  

  • 27. Catecholamine turnover in rat cerebral cortex and caudate following repeated treatment with dihydroergotoxine.
    Cvejić V; Mrsulja BB
    Gerontology; 1981; 27(1-2):7-12. PubMed ID: 6111518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of reserpine and a tyrosine hydroxylase inhibitor on the monoamine levels in different regions of the rat central nervous system.
    Andén NE
    Eur J Pharmacol; 1967 Jan; 1(1):1-5. PubMed ID: 6058896
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of ouabain on catecholamine biosynthesis in rat brain cortex slices.
    Goldstein M; Ohi Y; Backstrom T
    J Pharmacol Exp Ther; 1970 Jul; 174(1):77-82. PubMed ID: 5424706
    [No Abstract]   [Full Text] [Related]  

  • 30. Operant behavior and catecholamine-containing neurons: prolonged increase in lever-pressing after 6-hydroxydopamine.
    Schoenfeld RI; Uretsky NJ
    Eur J Pharmacol; 1972 Dec; 20(3):357-62. PubMed ID: 4643457
    [No Abstract]   [Full Text] [Related]  

  • 31. Antiamphetamine effects following inhibition of tyrosine hydroxylase.
    Weissman A; Koe BK; Tenen SS
    J Pharmacol Exp Ther; 1966 Mar; 151(3):339-52. PubMed ID: 5938473
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of brain norepinephrine in audiogenic seizure in the rat.
    Jobe PC; Picchioni AL; Chin L
    J Pharmacol Exp Ther; 1973 Jan; 184(1):1-10. PubMed ID: 4686009
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of disulfiram and diethyldithiocarbamate on spontaneous locomotor activity and brain catecholamine levels in mice.
    Moore KE
    Biochem Pharmacol; 1969 Jul; 18(7):1627-34. PubMed ID: 5806105
    [No Abstract]   [Full Text] [Related]  

  • 34. Brain catecholamines and the reserpine-induced stimulation of the pituitary-adrenal system.
    Hirsch GH; Moore KE
    Neuroendocrinology; 1968; 3(6):398-405. PubMed ID: 4388076
    [No Abstract]   [Full Text] [Related]  

  • 35. The influence of sympathetic nervous activity on cardiac catecholamine levels.
    Bhagat B
    J Pharmacol Exp Ther; 1967 Jul; 157(1):74-80. PubMed ID: 4382101
    [No Abstract]   [Full Text] [Related]  

  • 36. The mechanism of the tranquillizing action of asarone from Acorus calamus Linn.
    Menon MK; Dandiya PC
    J Pharm Pharmacol; 1967 Mar; 19(3):170-5. PubMed ID: 4382337
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of electroconvulsive shock and prior stress on brain amine levels.
    Nielson HC; Fleming RM
    Exp Neurol; 1968 Jan; 20(1):21-30. PubMed ID: 5300035
    [No Abstract]   [Full Text] [Related]  

  • 38. Behavioral effects of L-alpha-methyltyrosine, an inhibitor of tyrosine hydroxylase.
    Weissman A; Koe BK
    Life Sci; 1965 May; 4(10):1037-48. PubMed ID: 5838507
    [No Abstract]   [Full Text] [Related]  

  • 39. [The brain catecholamine systems in the regulation of dominance].
    Serova LI; Naumenko EV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1990; 40(3):490-6. PubMed ID: 1975967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Catalepsy, sedation and hypothermia induced by alpha-methyl-p-tyrosine in the rat. An ideal tool for screening of drugs active on central catecholaminergic receptors.
    Papeschi R; Randrup A
    Pharmakopsychiatr Neuropsychopharmakol; 1973 May; 6(3):137-57. PubMed ID: 4800160
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.